515 related articles for article (PubMed ID: 26269227)
1. Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
Hurd YL; Yoon M; Manini AF; Hernandez S; Olmedo R; Ostman M; Jutras-Aswad D
Neurotherapeutics; 2015 Oct; 12(4):807-15. PubMed ID: 26269227
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and substance use disorder: Dream or reality.
Karimi-Haghighi S; Razavi Y; Iezzi D; Scheyer AF; Manzoni O; Haghparast A
Neuropharmacology; 2022 Apr; 207():108948. PubMed ID: 35032495
[TBL] [Abstract][Full Text] [Related]
3. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.
Gonzalez-Cuevas G; Martin-Fardon R; Kerr TM; Stouffer DG; Parsons LH; Hammell DC; Banks SL; Stinchcomb AL; Weiss F
Neuropsychopharmacology; 2018 Sep; 43(10):2036-2045. PubMed ID: 29686308
[TBL] [Abstract][Full Text] [Related]
4. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol - therapeutic and legal aspects.
Vlad RA; Hancu G; Ciurba A; Antonoaea P; Rédai EM; Todoran N; Silasi O; Muntean DL
Pharmazie; 2020 Oct; 75(10):463-469. PubMed ID: 33305718
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol in the context of substance use disorder treatment: A systematic review.
Paulus V; Billieux J; Benyamina A; Karila L
Addict Behav; 2022 Sep; 132():107360. PubMed ID: 35580370
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
[TBL] [Abstract][Full Text] [Related]
9. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.
Zavala-Tecuapetla C; Luna-Munguia H; López-Meraz ML; Cuellar-Herrera M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555823
[TBL] [Abstract][Full Text] [Related]
10. Considerations and Implications of Cannabidiol Use During Pregnancy.
Sarrafpour S; Urits I; Powell J; Nguyen D; Callan J; Orhurhu V; Simopoulos T; Viswanath O; Kaye AD; Kaye RJ; Cornett EM; Yazdi C
Curr Pain Headache Rep; 2020 Jun; 24(7):38. PubMed ID: 32524214
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review.
Balachandran P; Elsohly M; Hill KP
J Gen Intern Med; 2021 Jul; 36(7):2074-2084. PubMed ID: 33515191
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry.
Bellocchio L; Patano A; Inchingolo AD; Inchingolo F; Dipalma G; Isacco CG; de Ruvo E; Rapone B; Mancini A; Lorusso F; Scarano A; Malcangi G; Inchingolo AM
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298644
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
Mlost J; Bryk M; Starowicz K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Status of Cannabidiol in the United States: A Perspective.
Corroon J; Kight R
Cannabis Cannabinoid Res; 2018; 3(1):190-194. PubMed ID: 30283822
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP
Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA; Raup-Konsavage WM; Vrana KE
Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
[TBL] [Abstract][Full Text] [Related]
19. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
